Regulatory Approval for Striate in US$65M Brazilian Market
Filed with ASX · · 3 pages · English
Story so far
Earlier from Orthocell
- Remplir Cleared to Commence Sales in US$1.6B US Market
- Investor Presentation - US FDA 510(k) Clearance for Remplir
- First Sales of Striate in Germany, Austria & Swiss Region
- Regulatory approval to commence Striate sales in Singapore
- S&P DJI Announces March 2025 Quarterly Rebalance
Later from Orthocell
- First US Distributors Signed for Remplirs US$1.6B market
- Remplir Approved to Commence Sales in US$84M Thai Market
- Pause in Trading
- Replacement Trading Halt
- Remplir Approved to Commence Sales in US$75m Canadian Market
Follow Orthocell into a list and get an email when it puts out news.
Follow Orthocell